Kubo et al, Page 3 Therapeutic angiogenesis induced by the implantation of peripheral blood mononuclear cells (PBMNCs) or bone marrow cells has been demonstrated as a promising approach for treating several ischemic diseases (2, 8, 12, 15-17, 25, 30) . Originally, it was thought that cell-based therapeutic angiogenesis was related to the secretion of angiogenic factors, such as vascular endothelial growth factor (VEGF), and also to endothelial differentiation from implanted cells (2, 15) . However, the survival of implanted cells decreases rapidly within a few days in ischemic tissues (13, 31, 35) .
Ischemic tissue is characterized by low levels of oxygen and high levels of inflammatory cytokines, resulting in the excessive production of reactive oxygen species (ROS) (5, 22) . As the accumulation of ROS causes cell death by both apoptosis and necrosis (24, 28) , the poor survival of implanted cells in ischemic tissue is attributed at least in part to the oxidative stress of the ischemic microenvironment. Therefore, increasing the resistance of implanted cells against oxidative stress could be a feasible strategy for enhancing the therapeutic potency of cell-based angiogenesis.
Ischemic preconditioning, induced by a brief episode of mild and non-lethal reduced oxygen supply, is known to protect cells or organs from damage caused by subsequent prolonged and severe ischemia (3, 4, 6) . The protective effects are in part due to enhancement of the cell's resistance to oxidative stress by upregulating the genes associated with antioxidant and cell survival (6) . Our previous studies, like those of others, showed that the implantation of hypoxia-pretreated bone marrow cells or endothelial progenitor cells improved therapeutic angiogenesis through the upregulation of VEGF (1, 18) . However, the cytoprotective mechanism of hypoxic pretreatment has not been investigated. Based on the well-known concept of ischemic preconditioning, we speculated that the improved therapeutic angiogenesis of ex vivo hypoxia-pretreated cells is related to this preconditioning effect.
We conducted this study to examine whether the hypoxic preconditioning of PBMNCs enhanced resistance to oxidative stress. We also investigated if increasing the survival of hypoxic preconditioned PBMNCs improved angiogenic potency after implantation into the ischemic hindlimbs of mice.
MATERIALS AND METHODS
Animals. C57BL/6 mice were purchased from Japan SLC (Shizuoka, Japan). C57BL/6 transgenic mice expressing enhanced green fluorescent protein (GFP) were kindly provided by Masaru Okabe (Genome Research Center, Osaka University, Osaka) (23) and bred in the Animal Center of Yamaguchi University. All experiments were approved by the Institutional Animal Care and Use Committee of Yamaguchi University.
Isolation and hypoxic preconditioning of PBMNCs. Mice were injected subcutaneously with 100 µg/kg granulocyte colony stimulating factor (Kyowa Hakko kogyo Co., Tokyo, Japan) daily for 5 days. Blood was collected from the inferior vena cavae of the anesthetized mice, 3 h after the last injection. PBMNCs were isolated by density gradient centrifugation using Lympholyte-Mammal (Cedarlane laboratories Ltd., Ontario, Canada), and suspended at a density of 5 × 10 6 /ml in RPMI 1640 medium containing 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin.
Hypoxic preconditioning of PBMNCs was done by 24 h of culture at 33˚C in 2% O 2 :5% CO 2 :93% N 2 (hypoxia-preconditioned), as described previously (18) . Freshly collected or normoxia-cultured (24 h at 33˚C in 95% air:5% CO 2 ) PBMNCs were used for controls. The density of each band was quantified using NIH image software and levels of each gene were normalized to that of GAPDH. Data were obtained from three independent experiments.
Assessment of oxidative stress resistance. To find out if hypoxic preconditioning
increased the tolerance of PBMNCs against oxidative stress, hypoxia-preconditioned and normoxia-cultured PBMNCs were collected, washed, and resuspended in RPMI 1640 medium containing 10% FBS and 1% penicillin-streptomycin. Cells were seeded on 96-well culture plates (2 × 10 5 /100 µl /well) and then incubated at 37˚C in 95% air:5% CO 2 . Oxidative stress was induced by adding superoxide generating compound LY83583 (10 µM, Sigma, St. Louis, MO), which increases intracellular formation of superoxide via the metabolism of cytosolic and membrane-bound NAD(P)H oxidases (26) . After 24 h of incubation, we evaluated the intracellular ROS level and cell viability.
Intracellular ROS levels were measured using the fluorescent probe,
Technologie, Graz, Austria), as described previously (14) . Briefly, cells were washed and then incubated with 20 µM DCF for 30 min at 37˚C in the dark. After washing, fluorescence was measured immediately in a microplate reader with an Ischemic hindlimb model and cell implantation. The mouse ischemic hindlimb model was created as described previously (16) (17) (18) . Briefly, after the mice were given general anesthesia, the left femoral artery was exposed and ligated, and its branches were dissected free and excised. The quadriceps and adductor muscles of the ischemic hindlimbs were injected intramuscularly at four points, with 10 µl PBS or 0.5 × 10 6 cells/point. The mice were divided randomly into the following four groups: the PBS group, injected with PBS only (n=5); the fresh group, injected with 2 × 10 6 freshly isolated PBMNCs (n=5); the normoxia group, injected with 2 × 10 6 normoxia-cultured PBMNCs (n=7); and the hypoxia group, injected with 2 × 10 6 hypoxia-preconditioned PBMNCs (n=7).
Assessment of cell survival in vivo.
To evaluate the survival of cells after implantation,
PBMNCs taken from GFP-transgenic mice were injected into the ischemic hindlimbs as described above, excluding the PBS group. Mice were euthanized 3 days after treatment and the quadriceps and adductor muscles were harvested and embedded in OCT Histological analysis of microvessel density. Mice were euthanized 28 days after treatment and the quadriceps and adductor muscles were harvested. To detect the development of microvessels in the ischemic muscles, frozen sections were stained for alkaline phosphatase with an indoxyl tetrazolium method, as described previously (16) (17) (18) . A total of 20 different fields (× 200-fold magnification) on three independent slides from different cross-sections were randomly selected for each mouse, and the number of microvessels was counted. The density of microvessels was expressed as the number of microvessels/mm 2 .
Measurement of blood flow in the ischemic hindlimbs. Blood flow in the ischemic hindlimb was measured using a laser Doppler perfusion imaging system (PeriScan System, Perimed AB, Stockholm, Sweden), before, and 3, 7, 14, 21 and 28 days after treatment, as described previously (16, 17) . Briefly, both normal and ischemic feet were scanned while the animal was under light anesthesia, and mean perfusion scores were obtained for each foot. The recovery of perfusion in the ischemic hindlimb of each mouse was estimated by the percentage of limb blood flow, calculated by the average perfusion score in the left hindlimb compared with that in the normal right hindlimb.
Statistical analysis. All data are expressed as means ± SEM. Differences between mean values of multiple groups were evaluated by ANOVA followed by Scheffe's procedure.
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Comparisons between two groups were made using the unpaired Student t test. A value of P < 0.05 was considered significant. All analyses were performed with StatView software (Version 5.0).
RESULTS

Hypoxic preconditioning increases the expression of cytoprotective genes in PBMNCs.
We analyzed the gene expression in PBMNCs after 24 h of culture under normoxic and hypoxic conditions, by using the pathway-focused array. The hypoxia-preconditioned cells expressed higher levels ( 1.5 fold) of genes related to antioxidant and cell survival, including heme oxygenase-1, autocrine motility factor, hexokinase-2,
interleukin-1 IL-1 VEGF, and inducible nitric oxide synthase (iNOS), than the normoxia-cultured cells (Fig. 1A and B ). The expression of selected genes of interest was further confirmed by RT-PCR. The expression of mRNA for heme oxygenase-1, autocrine motility factor, and hexokinase-2 was significantly higher in the hypoxia-preconditioned cells than in the normoxia-cultured cells (P < 0.05) (Fig. 1C and   D ).
Hypoxic preconditioning enhances the resistance of PBMNCs to oxidative stress. Under
oxidative stress induced by incubation with LY83583, ROS accumulation in the hypoxia-preconditioned cells was significantly lower than that in the normoxia-cultured cells (P < 0.05) ( Fig. 2A) . Furthermore, the cell survival in response to LY83583 was significantly higher in the hypoxia-preconditioned PBMNCs than in the normoxia-cultured PBMNCs (P < 0.05) (Fig. 2B) . These results suggest that 24 h ex vivo hypoxic preconditioning enhanced the oxidative stress resistance of PBMNCs. On the other hand, ROS accumulation and survival after incubation without LY83583 was not significantly different between the hypoxia-preconditioned and normoxia-cultured PBMNCs ( Fig. 2C and D) .
Several antioxidant genes, including heme oxygenase-1, autocrine motility factor, and hexokinase-2, were increased in the hypoxia-preconditioned PBMNCs. To identify the specific factors contributing to oxidative stress resistance by hypoxic preconditioning, we examined the survival of hypoxia-preconditioned PBMNCs by adding chemicals to inhibit each of these factors. The survival rate of hypoxia-preconditioned PBMNCs under oxidative stress decreased significantly (P < 0.01), but partially by the blockade of heme oxygenase-1, autocrine motility factor, or hexokinase-2, respectively (Fig. 2B ). In contrast, the survival rate of normoxia-cultured PBMNCs was not affected by inhibiting each of these factors. This suggests that the enhanced oxidative stress resistance by hypoxic preconditioning was related to increased expression of multiple genes.
Increased survival of hypoxia-preconditioned PBMNCs in ischemic tissue. To estimate
whether hypoxic preconditioning could also increase the survival of PBMNCs in the ischemic microenvironment, we injected GFP-positive cells intramuscularly into the acute ischemic hindlimbs of mice. Although the same number of cells was delivered, we found that the survival of PBMNCs in ischemic hindlimbs was obviously better 3 days after the implantation of hypoxia-preconditioned PBMNCs than 3 days after the implantation of freshly-collected or normoxia-cultured PBMNCs (Fig. 3A) . Quantitative analysis showed significantly more GFP-positive cells in the hypoxia group than in the fresh and normoxia groups (P < 0.01) (Fig. 3B ).
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Increased microvessel density in the ischemic hindlimbs after the implantation of hypoxia-preconditioned PBMNCs. To detect microvessels in the ischemic muscles, staining for alkaline phosphatase was performed 28 days after treatment. Representative images of the microvessel density in each group are shown in Fig. 4A . Microvessel density was significantly higher in the hypoxia, normoxia, and fresh groups than in the PBS group (P < 0.01). Interestingly, the hypoxia group had the highest microvessel density, being significantly higher than that in either the fresh or normoxia groups (Fig.   4B ).
Improved blood flow in the ischemic hindlimbs after the implantation of
hypoxia-preconditioned PBMNCs. We took serial measurements of the perfusion of the ischemic hindlimbs before, then 3, 7, 14, 21, and 28 days after treatment. Laser Doppler perfusion imaging showed profound differences in blood flow of the ischemic hindlimbs at 28 days (Fig. 5A ). Quantitative analysis also showed that the percentage of limb blood flow was significantly higher in the hypoxia, normoxia, and fresh groups than in the PBS group. More importantly, the blood flow in the hypoxia group was significantly better (about 5-15%) than that in the normoxia and fresh groups, from 7 days after treatment onward (Fig. 5B) .
DISCUSSION
The findings of the present study support the hypothesis that increased oxidative stress resistance by ex vivo hypoxia-preconditioning of implanted cells enhances their therapeutic potency for inducing angiogenesis after implantation into ischemic tissue.
First, our in vitro studies revealed the upregulation of genes related to antioxidant and Kubo et al, Page 12 survival in hypoxia-preconditioned PBMNCs, which contributed to reduced intracellular ROS accumulation and increased cell survival under oxidative stress. Second, our in vivo studies showed that hypoxic preconditioning of PBMNCs increased viability after implantation into the ischemic hindlimbs of mice, thereby contributing to increased angiogenic potency.
We found that hypoxic preconditioning increased the expression of various genes in PBMNCs, including the heme oxygenase-1, autocrine motility factor, and hexokinase-2.
Heme oxygenase-1 helps protect against oxidative stress (21) and ischemia-induced injury (20, 34) . Gene modification of stem cells with heme oxygenase-1 was found to increase their viability after implantation into ischemic tissue (29) . Moreover, autocrine motility factor (11, 32) and hexokinase-2 (19) contribute to an anti-apoptotic effect.
Under oxidative stress induced by LY83583, the hypoxia-preconditioned PBMNCs in this study showed less accumulation of intracellular ROS, and survived better. We think that this reduced accumulation of ROS is partly responsible for the increased survival of PBMNCs. Given that the ROS accumulation and survival rate did not differ significantly from those without LY83583, we propose that hypoxic preconditioning can enhance the resistance of PBMNCs against oxidative stress. Furthermore, the fact that the survival of hypoxia-preconditioned PBMNCs under oxidative stress was decreased by the addition of protoporphtrin IX zinc (II) (ZnPP), D -erythrose 4-phosphate (E4P), or clotrimazole (CTZ) indicated that the enhanced expression of heme oxygenase-1, hexokinase-2, or autocrine motility factor all played a role in protecting PBMNCs against oxidative stress.
On the other hand, our microarray analysis showed that hypoxic preconditioning increased the expression of VEGF, IL-1 , and iNOS in PBMNCs. VEGF is known to regulate not only angiogenesis but also cell survival (9, 10) . IL-1 also has a positive Page 12 of 27
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Kubo et al, Page 13 effect on the survival and angiogenic potential of bone marrow cells (27) , and iNOS-derived NO has been shown to play a role in VEGF expression (7, 33) . The upregulation of these factors by hypoxic preconditioning could enhance the oxidative stress resistance and angiogenic potency of PBMNCs.
To investigate whether hypoxic preconditioning increased the survival and angiogenic potency of PBMNCs in vivo, we implanted PBMNCs into the ischemic hindlimbs of mice. As we expected, the survival of hypoxia-preconditioned PBMNCs was better than that of freshly isolated or normoxia-cultured PBMNCs. This supports our hypothesis that Interestingly, a recent study has reported that overexpression of heme oxygenase-1 in stem cells increased cell viability within ischemic tissue after implantation and thereby improved the effectiveness of cell-based angiogenesis (29) .
In conclusion, the present study showed that hypoxic preconditioning of PBMNCs increased their resistance to oxidative stress, and contributed to increased survival and angiogenic potency after implantation into the ischemic limbs of mice. Thus, the increased resistance of implanted cells to oxidative stress by hypoxia-or drug-preconditioning is a feasible and effective strategy for enhancing the therapeutic Arrows indicate the ischemic hindlimbs. B, Quantitative analysis of the time course recovery of blood flow in the ischemic limbs. *P < 0.05, **P < 0.01, and ***P < 0.001 vs.
PBS group. †P < 0.05, † † †P < 0.001 vs. fresh and normoxia groups (n=5 or 7 animals/group).
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